Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2015

Nov 13, 2015

34519_dirs_2015-11-13_bcbe317c-226a-4797-8d85-308f748dfd99.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2015-11-11

Reporting Person: ROTHSCHILD JONATHAN E (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-11-11 Common Stock, par value $0.10 per share P 24000.0000 $0.0000 Disposed 500636.0000 Direct

Footnotes

F1: These 24,000 shares were distributed from the estate of Mr. Rothschild's parents to the two sisters of Mr. Rothschild, as to which Mr. Rothschild disclaims beneficial ownership. Mr. Rothschild is the executor of his parents' estate and now owns 19,255 shares from the estate directly, which are included in the 500,636 shares disclosed above in Table I, Column 5.

F2: This figure includes 221,655 shares of common stock held by Arterio Inc., a corporation owned solely by Mr. Rothschild.